Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

23.08
+0.47002.08%
Post-market: 23.080.00000.00%16:05 EDT
Volume:396.10K
Turnover:9.10M
Market Cap:1.68B
PE:-38.17
High:23.11
Open:22.68
Low:22.54
Close:22.61
Loading ...

Company Profile

Company Name:
Kiniksa Pharmaceuticals Ltd.
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
315
Office Location:
23 Old Bond Street,Floor 3,London,Greater London,United Kingdom
Zip Code:
WIS 4PZ
Fax:
- -
Introduction:
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.

Directors

Name
Position
Sanj K. Patel
Chief Executive Officer and Chairman of our Board of Director
Felix J. Baker
Lead Independent Director
Barry D. Quart
Director
Kimberly J. Popovits
Director
Richard S. Levy
Director
Stephen R. Biggar
Director
Thomas R. Malley
Director
Tracey L. McCain
Director

Shareholders

Name
Position
Sanj K. Patel
Chief Executive Officer and Chairman of our Board of Director
Chris Heberlig
Chief Financial Officer and Treasurer
Qasim Rizvi
Senior Vice President of Operations & Chief Commercial Officer
John F. Paolini
Chief Medical Officer
Thomas Beetham
Executive Vice President, Corporate Development and Operations,Chief Legal Officer